Cibus

Cibus Total Assets

The Total Assets of Cibus (CBUS) as of Oct 29, 2026 is 305.05 M USD. In the previous year, Total Assets was 350.07 M USD — a change of -12.86% (lower).

Total Assets

305.05 MUSD

YoY

-12.86%

Last updated:

Total Assets of Cibus is 2025 305.05 M USD. Total Assets of Cibus was 2024 350.07 M USD. It decreases by -12.86% lower compared to the previous year.

The Cibus Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
118.79 M USD
Jan 1, 2019
88.10 M USD
Jan 1, 2020
63.33 M USD
Jan 1, 2021
37.19 M USD
Jan 1, 2022
22.42 M USD
Jan 1, 2023
544.41 M USD
Jan 1, 2024
350.07 M USD
Jan 1, 2025
305.05 M USD
The Cibus Total Assets history
YEARTotal AssetsYoY
305.05 MUSD-12.86%
350.07 MUSD-35.70%
544.41 MUSD+2,328.13%
22.42 MUSD-39.72%
37.19 MUSD-41.27%
63.33 MUSD-28.12%
88.10 MUSD-25.84%
118.79 MUSD+64.61%
72.17 MUSD+334.14%
16.62 MUSD-36.05%
26.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cibus Stock analysis

What does Cibus do? Cibus, Inc. generates revenue through the development and licensing of plant traits to seed companies, earning royalties on seed sales. The company utilizes its patented RTDS technology platform, including the Trait Machine, a semi-automated trait production facility that accelerates trait development speed, breadth, and scale. Cibus focuses on gene-edited traits indistinguishable from traditional breeding, targeting productivity and sustainable ingredients to address climate change, disease, and pest challenges. Seed companies are the primary buyers of these traits, leveraging Cibus's technology for improved crop performance and sustainability. The company's business model centers on royalties from seed sales, with its RTDS platform enabling efficient trait creation. Cibus emphasizes gene-edited traits that align with traditional breeding outcomes, appealing to seed companies seeking sustainable solutions. The firm's focus on climate resilience, disease resistance, and pest management drives demand for its proprietary technology among seed industry partners. Cibus's revenue stream is derived from licensing agreements with seed companies, where royalties are tied to seed sales. The Trait Machine, part of the RTDS platform, allows for rapid development of traits that enhance crop productivity and sustainability. By addressing key agricultural challenges through gene editing, Cibus positions itself as a provider of innovative solutions for seed companies aiming to meet evolving market demands. Cibus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cibus stock

Total Assets of Cibus is 305.05 M USD in 2025.

Total Assets of Cibus changed from 350.07 M USD to 305.05 M USD, representing a -12.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Cibus since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Cibus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cibus

All Key Metrics — Cibus